MAPS Act

Summary

Mapping America's Pharmaceutical Supply Act or the MAPS Act This bill requires the Department of Health and Human Services (HHS) to support efforts to map the U.S. pharmaceutical supply chain and identify associated vulnerabilities. As part of these efforts, HHS must support the development of a database of certain essential medicines and the identification of information about their supply chain, including the location of manufacturing facilities. Qualifying essential medicines are those that are likely to be needed in the event of a public health emergency or chemical, biological, radiological, or nuclear threat or for which a shortage would pose a significant threat to the U.S. health care system or at-risk populations. 

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 18 July 2023

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 18 July 2023

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 18 July 2023

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.